Patients News | pharmaphorum

News

Neuralink raises $650m to widen use of brain implants

Brain-computer interface firm Neuralink has completed a $650m financing that it says will help to "bring our technology to more people."

News

Hims & Hers buys Zava to form European beachhead

US telehealth company Hims & Hers has reached a deal to buy its UK counterpart Zava as part of a broader push into Europe.

News

Stealth BioTherapeutics' chief executive Reenie McCarthy

Axe falls on Stealth Bio staff after FDA rejects lead drug

Stealth BioTherapeutics' filing for Barth syndrome therapy elamipretide has been turned down by the FDA, but there may be a way forward for the drug.

News

Moderna's $760m-plus flu vaccine contracts are nixed by HHS

HHS cancels funding for Moderna's pandemic flu vaccine development in a move viewed by some as an attack on mRNA technology.

News

CDC stops backing COVID jabs for pregnant women, children

In a new sign of downgraded support for COVID-19 shots by the US administration, the CDC has stopped backing vaccines for pregnant women and children.

News

Sanofi admits giving free Olympics tickets to patients

Despite a voluntary admission of a breach of the ABPI code, Sanofi is deemed to have "brought discredit" on the pharma industry.

Neuralink raises $650m to widen use of brain implants

Hims & Hers buys Zava to form European beachhead

Axe falls on Stealth Bio staff after FDA rejects lead drug

Moderna's $760m-plus flu vaccine contracts are nixed by HHS

CDC stops backing COVID jabs for pregnant women, children

Sanofi admits giving free Olympics tickets to patients

ESC26: Isomab safety evidence on blood vessel growth for CAD

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks